# Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Kidney Lesions

> **NCT01141816** · NA · UNKNOWN · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 30 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **OTHER:** Contrast-Enhanced Ultrasound

## Key facts

- **NCT ID:** NCT01141816
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141816, "Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Kidney Lesions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01141816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*